Related Experiment Video
Updated: Apr 22, 2026

Real-time Cytotoxicity Assays in Human Whole Blood
Published on: November 7, 2014
Immunotoxicology and the new biotechnology
1Joy Cavagnaro is a Senior Staff Scientist at Hazleton Laboratories America, Vienna, VA 22075, USA.
Abstract:
The use of recombinant DNA techniques, cell fusion and novel bioprocessing in the pharmaceutical industry has assisted the development of many kinds of diagnostic and therapeutic products. Some directly affect the immune system (e.g. interleukins, interferons, tumour necrosis factor, and colony stimulating factors). Others (e.g. peptides, cytokines, growth factors, H2-receptor antagonists, non-steroidal anti-inflammatory drugs and neurohormonal agents) have immunological reactivity even though they are not designed to be immune modulators. The need to define the immunotoxicological potential of these products during preclinical safety evaluation was among the topics discussed at a recent meeting.
More Related Videos
08:17A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research
Published on: August 15, 2019
09:03Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
Published on: June 19, 2018
Related Concept Videos
Tumor Immunotherapy
Microorganisms in Medicine and Therapeutics
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Toxicity Testing in Animals
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Bioactivation and Tissue Toxicity